Ellison Mark Jason Heath Insider Trades

Insider Trading History

Track insider trading activity for Ellison Mark Jason Heath. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $242k 11,736 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$727k 35,215 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $41.3k 2,000 shares
Last Trade
Mar 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 2,000 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $387k 18,751 shares
Last Trade
Jan 27, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.4k 610 shares
$20.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $400k 19,361 shares
Last Trade
Jan 09, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.47k 469 shares
$20.20
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $409k 19,830 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$36.5k 1,806 shares
$20.20
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $447k 21,636 shares
Last Trade
Jun 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.5k 2,000 shares
$11.73
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $405k 19,636 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$394k 12,000 shares
$32.85
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Development Officer
Holding Value $222k 10,750 shares
Last Trade
Jan 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$223k 18,386 shares
$12.15
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $200k 9,680 shares
Last Trade
Jan 07, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 12,400 shares
$13.60
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $620k 30,000 shares
Last Trade
Jul 29, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 30,000 shares
$12.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $0 0 shares
Last Trade
Jul 29, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 30,000 shares
$12.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $114k 5,530 shares
Last Trade
Jul 29, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$300k 24,470 shares
$12.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $0 0 shares
Last Trade
Jul 29, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 30,000 shares
$12.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $620k 30,000 shares
Last Trade
Jul 29, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 30,000 shares
$12.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $114k 5,530 shares
Last Trade
Jul 29, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$300k 24,470 shares
$12.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $0 0 shares
Last Trade
Feb 13, 2019 Sale
$1.48M 100,000 shares
$14.75
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $0 0 shares
Last Trade
Feb 13, 2019 Sale
$1.48M 100,000 shares
$14.75
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $0 0 shares
Last Trade
Feb 03, 2019 Sale
$110k 7,200 shares
$15.28
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $0 0 shares
Last Trade
Feb 03, 2019 Sale
$110k 7,200 shares
$15.28
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Holding Value $0 0 shares
Last Trade
Jan 02, 2015 Sale
$340 10,000 shares
$0.03
$20.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up